Christopher Posner - Nov 4, 2024 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Nov 4, 2024
Transactions value $
-$1,064
Form type
4
Date filed
11/6/2024, 04:51 PM
Previous filing
Aug 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$1.06K -3.67K -2.13% $0.29 169K Nov 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.